SMAC Mimetic BV6 Enables Sensitization of Resistant Tumor Cells but also Affects Cytokine-Induced Killer (CIK) Cells: A Potential Challenge for Combination Therapy

Allogeneic hematopoietic stem cell transplantation (HSCT) is an established treatment option for high-risk hematological malignancies, and may also be offered to patients with solid malignancies refractory to conventional therapies. In case of patients’ relapse, refractory tumor cells may then be ta...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Rettinger, Eva, Glatthaar, Andreas, Abhari, Behnaz Ahangarian, Oelsner, Sarah, Pfirrmann, Verena, Huenecke, Sabine, Kuçi, Selim, Kreyenberg, Hermann, Willasch, Andre M., Klingebiel, Thomas, Fulda, Simone, Bader, Peter
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2014
Assuntos:
Pediatrics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4103003/
https://ncbi.nlm.nih.gov/pubmed/25101252
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fped.2014.00075
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados